Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

Chairman and CEO

President & COO

Chairman, President and CEO

President and CEO

First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients; and niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties. The company develops FW-COV, which is in Phase II clinical trials for the treatment of severe acute respiratory syndrome coronavirus 2 gastrointestinal infections; FW-UP, which is in Phase II clinical trials for the treatment ulcerative proctitis and ulcerative proctosigmoiditis; FW-ICI-AC for immune checkpoint inhibitor-associated colitis and diarrhea in advanced stage oncology patients; and FW-UC, which is in Phase Ib/IIa clinical trials for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis. It also develops FW-CD, which has completed Phase I clinical trials for Crohn's disease; and adrulipase, an oral, non-systemic, and biologic capsule for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis and chronic pancreatitis. The company was formerly known as AzurRx BioPharma, Inc. and changed its name to First Wave BioPharma, Inc. in September 2021. First Wave BioPharma, Inc. was incorporated in 2014 and is headquartered in Boca Raton, Florida.

First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-system...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-01	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-04-01	Premium	sold	Premium	Premium	Premium	Chairman and CEO
2024-03-15	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-03-15	Premium	sold	Premium	Premium	Premium	Chairman and CEO
2024-03-13	Premium	acquired	Premium	Premium	Premium	President & COO
2024-03-13	Premium	acquired	Premium	Premium	Premium	-
2024-01-12	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-01-12	Premium	sold	Premium	Premium	Premium	Chairman, President and CEO
2024-01-02	Premium	acquired	Premium	Premium	Premium	-
2024-01-02	Premium	acquired	Premium	Premium	Premium	-
2024-01-02	Premium	acquired	Premium	Premium	Premium	-
2024-01-02	Premium	acquired	Premium	Premium	Premium	-
2024-01-02	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-01-02	Premium	acquired	Premium	Premium	Premium	Chairman, President and CEO
2023-12-29	Premium	acquired	Premium	Premium	Premium	Chairman, President and CEO
2023-12-29	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-10-04	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-10-04	Premium	sold	Premium	Premium	Premium	President and CEO
2023-09-15	Premium	sold	Premium	Premium	Premium	-
2023-08-31	Premium	sold	Premium	Premium	Premium	-
2023-07-03	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-07-03	Premium	sold	Premium	Premium	Premium	President and CEO
2023-04-03	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-04-03	Premium	sold	Premium	Premium	Premium	President and CEO
2023-01-03	Premium	acquired	Premium	Premium	Premium	-

FWBI - First Wave BioPharma, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for FWBI